Arsenic methylation capacity and its correlation with skin lesions induced by contaminated drinking water consumption in residents of chronic arsenicosis area

Environmental Toxicology

Volumn 26, Issue 2, 2011, Pages 118-123

  Li, Xin ^a   Li, Bing ^a   Xu, Yuanyuan ^a   Wang, Yi ^a   Jin, Yaping ^a   Itoh, Toshihiro ^b   Yoshida, Takahiko ^b   Sun, Guifan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Arsenic; Chronic arsenicosis; Drinking water; Methylation; Skin lesions

Indexed keywords

CHRONIC ARSENICOSIS; CHRONIC EXPOSURE; CONTAMINATED DRINKING WATER; CORRELATION COEFFICIENT; DIMETHYLARSINIC ACIDS; DRINKING WATER; INORGANIC ARSENIC; METHYLATION CAPACITY; MONOMETHYLARSONIC ACIDS; NEGATIVE CORRELATION; SKIN LESION; SKIN LESIONS; URINARY ARSENIC;

ALKYLATION; BLOOD; DERMATOLOGY; METHYLATION; POTABLE WATER; RATING; WATER SUPPLY;

ARSENIC;

ARSENIC; CACODYLIC ACID; DRINKING WATER; INORGANIC ARSENIC; METHANEARSONIC ACID; UNCLASSIFIED DRUG;

ARSENIC; BLOOD; CONCENTRATION (COMPOSITION); DRINKING WATER; LESION; METHYLATION; POLLUTION EFFECT; SKIN; SPECIATION (CHEMISTRY); WATER POLLUTION; WATER USE;

ADULT; ARSENIC POISONING; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; METHYLATION; PRIORITY JOURNAL; SKIN DEFECT; WATER CONTAMINATION;

ADULT; ARSENIC; ARSENIC POISONING; ARSENICALS; CACODYLIC ACID; FEMALE; HUMANS; MALE; METHYLATION; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SKIN DISEASES; WATER POLLUTANTS, CHEMICAL; WATER SUPPLY;

EID: 79952773633     PISSN: 15204081     EISSN: 15227278     Source Type: Journal    
DOI: 10.1002/tox.20535     Document Type: Article

References (33)

1. Abernathy CO, Liu YP, Longfellow D, Aposhian HV, Beck B, Fowler B, Goyer R, Menzer R, Rossman T, Thompson C, Waalkes M. 1999. Arsenic: Health effects, mechanisms of actions, and research issues. Environ Health Perspect 107: 593-597.
2. Anetor JI, Wanibuchi H, Fukushima S. 2007. Arsenic exposure and its health effects and risk of cancer in developing countries: Micronutrients as host defence. Asian Pac J Cancer Prev 8: 13-23.
3. Aposhian HV. 1997. Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu Rev Pharmacol Toxicol 37: 397-419.
4. Aposhian HV, Zakharyan RA, Avram MD, Sampayo-Reyes A, Wollenberg ML. 2004. A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in detoxication of the trivalent arsenic species. Toxicol Appl Pharmacol 198: 327-335.
5. Bates MN, Smith AH, Hopenhayn-Rich C. 1992. Arsenic ingestion and internal cancers: A review. Am J Epidemiol 135: 462-476.
6. Chen YC, Su HJ, Guo YL, Hsueh YM, Smith TJ, Ryan LM, Lee MS, Christiani DC. 2003a. Arsenic methylation and bladder cancer risk in Taiwan. Cancer Causes Control 14: 303-310.
7. Chen YC, Guo YL, Su HJ, Hsueh YM, Smith TJ, Ryan LM, Lee MS, Chao SC, Lee JY, Christiani DC. 2003b. Arsenic methylation and skin cancer risk in southwestern Taiwan. J Occup Environ Med 45: 241-248.
8. Chen CJ, Wang SL, Chiou JM, Tseng CH, Chiou HY, Hsueh YM, Chen SY, Wu MM, Lai MS. 2007. Arsenic and diabetes and hypertension in human populations: A review. Toxicol Appl Pharmacol 222: 298-304.
9. Engel RR, Hopenhayn-Rich C, Receveur O, Smith AH. 1994. Vascular effects of chronic arsenic exposure: A review. Epidemiol Rev 16: 184-209.
10. Gebel TW. 1999. Arsenic and drinking water contamination. Science 283: 1458-1459.
11. Guo X, Liu Z, Huang C, You L. 2006. Levels of arsenic in drinking-water and cutaneous lesions in Inner Mongolia. J Health Popul Nutr 24: 214-220.
12. Hayakawa T, Kobayashi Y, Cui X, Hirano S. 2005. A new metabolic pathway of arsenite: Arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19. Arch Toxicol 79: 183-191.
13. Hopenhayn-Rich C, Biggs ML, Smith AH, Kalman DA, Moore LE. 1996. Methylation study of a population environmentally exposed to arsenic in drinking water. Environ Health Perspect 104: 620-628.
14. Huang YK, Tseng CH, Huang YL, Yang MH, Chen CJ, Hsueh YM. 2007. Arsenic methylation capability and hypertension risk in subjects living in arseniasis-hyperendemic areas in southwestern Taiwan. Toxicol Appl Pharmacol 218: 135-142.
15. Huang YL, Hsueh YM, Huang YK, Yip PK, Yang MH, Chen CJ. 2009. Urinary arsenic methylation capability and carotid atherosclerosis risk in subjects living in arsenicosis-hyperendemic areas in southwestern Taiwan. Sci Total Environ 407: 2608-2614.
16. Kapaj S, Peterson H, Liber K, Bhattacharya P. 2006. Human health effects from chronic arsenic poisoning-A review. J Environ Sci Health A Tox Hazard Subst Environ Eng 41: 2399-2428.
17. Kurttio P, Komulainen H, Hakala E, Kahelin H, Pekkanen J. 1998. Urinary excretion of arsenic species after exposure to arsenic present in drinking water. Arch Environ Contam Toxicol 34: 297-305.
18. Mohri T, Hisanaga A, Ishinishi N. 1990. Arsenic intake and excretion by Japanese adults: A 7-day duplicate diet study. Food Chem Toxicol 28: 521-529.
19. Nickson R, McArthur J, Burgess W, Ahmed KM, Ravenscroft P, Rahman M. 1998. Arsenic poisoning of Bangladesh groundwater. Nature 395: 338.
20. Nordstrom DK. 2002. Public health. Worldwide occurrences of arsenic in ground water. Science 296: 2143-2145.
21. Oremland RS, Stolz JF. 2003. The ecology of arsenic. Science 300: 939-944.
22. Steinmaus C, Bates MN, Yuan Y, Kalman D, Atallah R, Rey OA, Biggs ML, Hopenhayn C, Moore LE, Hoang BK, Smith AH. 2006. Arsenic methylation and bladder cancer risk in case-control studies in Argentina and the United States. J Occup Environ Med 48: 478-488.
23. Styblo M, Drobna Z, Jaspers I, Lin S, Thomas DJ. 2002. The role of biomethylation in toxicity and carcinogenicity of arsenic: A research update. Environ Health Perspect 110: 767-771.
24. Sun GF. 2004. Arsenic contamination and arsenicosis in China. Toxicol Appl Pharmacol 198: 268-271.
25. Sun GF, Liu S, Li B, Li X, Sun X, Guo X, Qian C, Pi J. 2001. Current situation of endemic arsenicosis in China. Environ Sci 5: 425-434.
26. Sun GF, Liu JY, Sun DJ, Luong TV, Wang LY. 2004. Endemic Arsenicosis: A Clinical Diagnostic Manual with Photo Illustrations. Bangkok: East Asia and Pacific Regional Office, United Nations Children's Fund. p 17.
27. Sun GF, Li X, Pi J, Sun Y, Li B, Jin Y, Xu Y. 2006. Current research problems of chronic arsenicosis in China. J Health Popul Nutr 24: 176-181.
28. Sun GF, Xu YY, Li X, Jin Y, Li B, Sun X. 2007. Urinary arsenic metabolites in children and adults exposed to arsenic in drinking water in Inner Mongolia, China. Environ Health Perspect 115: 648-652.
29. Tondel M, Rahman M, Magnuson A, Chowdhury IA, Faruquee MH, Ahmad SA. 1999. The relationship of arsenic levels in drinking water and the prevalence rate of skin lesions in Bangladesh. Environ Health Perspect 107: 727-729.
30. Tseng CH. 2007. Metabolism of inorganic arsenic and non-cancerous health hazards associated with chronic exposure in humans. J Environ Biol 28: 349-357.
31. Tseng CH, Huang YK, Huang YL, Chung CJ, Yang MH, Chen CJ, Hsueh YM. 2005. Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Toxicol Appl Pharmacol 206: 299-308.
32. Yamauchi H, Yamamura Y. 1984. Metabolism and excretion of orally administered dimethylarsinic acid in the hamster. Toxicol Appl Pharmacol 174: 134-140.
33. Yoshida T, Yamauchi H, Sun G. 2004. Chronic health effects in people exposed to arsenic via the drinking water: Dose-response relationships in review. Toxicol Appl Pharmacol 198: 243-252.